NO833367L - Fremgangsmaate for fremstilling av terapeutisk aktive 1-fenyl-2(1h,3h)-indolon-derivater - Google Patents

Fremgangsmaate for fremstilling av terapeutisk aktive 1-fenyl-2(1h,3h)-indolon-derivater

Info

Publication number
NO833367L
NO833367L NO833367A NO833367A NO833367L NO 833367 L NO833367 L NO 833367L NO 833367 A NO833367 A NO 833367A NO 833367 A NO833367 A NO 833367A NO 833367 L NO833367 L NO 833367L
Authority
NO
Norway
Prior art keywords
phenyl
procedure
preparation
indolones
treatment
Prior art date
Application number
NO833367A
Other languages
English (en)
Other versions
NO161557C (no
NO161557B (no
Inventor
Harry R Howard
Reinhard Sarges
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO833367L publication Critical patent/NO833367L/no
Publication of NO161557B publication Critical patent/NO161557B/no
Publication of NO161557C publication Critical patent/NO161557C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/08Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00Ethers; Compounds having groups, groups or groups
    • C07C43/02Ethers
    • C07C43/20Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/225Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32Oxygen atoms
    • C07D209/34Oxygen atoms in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32Oxygen atoms
    • C07D209/38Oxygen atoms in positions 2 and 3, e.g. isatin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Dental Preparations (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO833367A 1982-09-20 1983-09-19 Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-fenyl-2(1h,3h)-indolin-derivater. NO161557C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/420,544 US4476307A (en) 1982-09-20 1982-09-20 Heteroylidene indolone compounds

Publications (3)

Publication Number Publication Date
NO833367L true NO833367L (no) 1984-03-21
NO161557B NO161557B (no) 1989-05-22
NO161557C NO161557C (no) 1989-08-30

Family

ID=23666904

Family Applications (1)

Application Number Title Priority Date Filing Date
NO833367A NO161557C (no) 1982-09-20 1983-09-19 Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-fenyl-2(1h,3h)-indolin-derivater.

Country Status (24)

Country Link
US (1) US4476307A (no)
EP (1) EP0104860B1 (no)
JP (1) JPS5976058A (no)
KR (1) KR860001270B1 (no)
AT (1) ATE25972T1 (no)
AU (1) AU543115B2 (no)
CA (1) CA1194871A (no)
DD (1) DD213211A5 (no)
DE (1) DE3370325D1 (no)
DK (1) DK157010C (no)
ES (3) ES8503328A1 (no)
FI (1) FI77446C (no)
GR (1) GR79732B (no)
HU (1) HU189747B (no)
IE (1) IE55923B1 (no)
IL (1) IL69758A (no)
NO (1) NO161557C (no)
NZ (1) NZ205638A (no)
PH (1) PH18297A (no)
PL (3) PL141370B1 (no)
PT (1) PT77360B (no)
SU (1) SU1272983A3 (no)
YU (4) YU189283A (no)
ZA (1) ZA836933B (no)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4879391A (en) * 1982-09-20 1989-11-07 Pfizer Inc. 1-Phenyl-2(1H,3H)-indolone psychotherapeutic agents
US4760083A (en) * 1986-04-10 1988-07-26 E. I. Dupont De Nemours & Company 3,3-disubstituted indolines
WO1990008146A1 (en) * 1989-01-10 1990-07-26 Pfizer Inc. Anti-inflammatory 1-heteroaryl-oxindole-3-carboxamides
US5078756A (en) * 1990-01-12 1992-01-07 Major Thomas O Apparatus and method for purification and recovery of refrigerant
US5158969A (en) * 1991-08-21 1992-10-27 Neurosearch A/S Indole derivatives as potassium channel blockers
US5760250A (en) * 1991-11-05 1998-06-02 Zeneca Limited Process for the preparation of 3-(α-methoxy)methylenebenzofuranones and intermediates therefor
DE19949209A1 (de) * 1999-10-13 2001-04-19 Boehringer Ingelheim Pharma In 5-Stellung substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel
CA2461812C (en) * 2001-09-27 2011-09-20 Allergan, Inc. 3-(arylamino)methylene-1,3-dihydro-2h-indol-2-ones as kinase inhibitors
MXPA04009365A (es) * 2002-03-27 2005-01-25 Lundbeck & Co As H Metodo para la manufactura de sertindol.
FR2847813A1 (fr) * 2002-11-29 2004-06-04 Oreal Compositions cosmetiques photoprotectrices contenant des derives de 3-(2-azacycloalkylidene)-1,3-dihydro-indol-2-one et utilisations
FR2847811B1 (fr) * 2002-11-29 2005-01-07 Oreal Composition filtrante contenant au moins un derive du dibenzoylmethane et au moins un derive de 3-(2-azacycloalkylidene)-1,3-dihydro-indol-2-one;procede de photostabilisation
KR20080023680A (ko) 2005-05-10 2008-03-14 인터뮨, 인크. 스트레스-활성화 단백질 키나제 시스템을 조절하기 위한피리돈 유도체
EP2296653B1 (en) 2008-06-03 2016-01-27 Intermune, Inc. Compounds and methods for treating inflammatory and fibrotic disorders
PT2380876E (pt) 2008-12-19 2014-11-20 Nippon Soda Co Derivado 1-heterodieno e agente de controlo de organismos nocivos
JP5537562B2 (ja) 2009-11-12 2014-07-02 日本曹達株式会社 1−ヘテロジエン誘導体および有害生物防除剤
AR092742A1 (es) 2012-10-02 2015-04-29 Intermune Inc Piridinonas antifibroticas
EP3610890A1 (en) 2012-11-14 2020-02-19 The Johns Hopkins University Methods and compositions for treating schizophrenia
JP6525437B2 (ja) 2014-04-02 2019-06-05 インターミューン, インコーポレイテッド 抗線維性ピリジノン

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3506683A (en) * 1963-10-07 1970-04-14 Upjohn Co 3-(2-pyrrolidinylidene)-3h-indoles
GB1237008A (en) * 1968-12-18 1971-06-30 Pfizer Ltd Novel indoline derivatives
US3723457A (en) * 1969-09-30 1973-03-27 Eisai Co Ltd Indoline-2-one derivatives and preparation thereof
GB1374414A (en) * 1972-06-12 1974-11-20 Sterling Drug Inc 1-acyl-3-amino-alkyl-indoles and their preparation
DE2557342A1 (de) * 1975-12-19 1977-06-30 Hoechst Ag Basisch substituierte indolderivate und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
ES8505951A1 (es) 1985-06-01
JPS6241711B2 (no) 1987-09-04
ES8505950A1 (es) 1985-06-01
PL250769A1 (en) 1985-07-02
ES531907A0 (es) 1985-06-01
PT77360B (en) 1986-05-19
DK157010B (da) 1989-10-30
ES525737A0 (es) 1985-02-16
IL69758A0 (en) 1983-12-30
KR860001270B1 (ko) 1986-09-04
PT77360A (en) 1983-10-01
PL141370B1 (en) 1987-07-31
EP0104860B1 (en) 1987-03-18
NZ205638A (en) 1986-12-05
KR840006239A (ko) 1984-11-22
NO161557C (no) 1989-08-30
FI833335A7 (fi) 1984-03-21
YU169386A (en) 1987-10-31
EP0104860A1 (en) 1984-04-04
ZA836933B (en) 1985-05-29
DE3370325D1 (en) 1987-04-23
YU169286A (en) 1987-10-31
CA1194871A (en) 1985-10-08
DK425383A (da) 1984-05-03
HU189747B (en) 1986-07-28
AU1925283A (en) 1984-03-29
FI833335A0 (fi) 1983-09-19
DK157010C (da) 1990-03-26
PL141609B1 (en) 1987-08-31
DK425383D0 (da) 1983-09-19
US4476307A (en) 1984-10-09
NO161557B (no) 1989-05-22
PH18297A (en) 1985-05-24
YU189283A (en) 1987-10-31
JPS5976058A (ja) 1984-04-28
ATE25972T1 (de) 1987-04-15
AU543115B2 (en) 1985-04-04
IL69758A (en) 1986-12-31
DD213211A5 (de) 1984-09-05
PL243826A1 (en) 1985-04-24
GR79732B (no) 1984-10-31
ES531908A0 (es) 1985-06-01
YU169186A (en) 1987-10-31
IE832193L (en) 1984-03-20
PL250768A1 (en) 1985-07-02
FI77446B (fi) 1988-11-30
ES8503328A1 (es) 1985-02-16
SU1272983A3 (ru) 1986-11-23
FI77446C (fi) 1989-03-10
IE55923B1 (en) 1991-02-27
PL141876B1 (en) 1987-09-30

Similar Documents

Publication Publication Date Title
NO833367L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1-fenyl-2(1h,3h)-indolon-derivater
TR199901172T2 (xx) Yeni ikame edilmi� pirazol t�revleri.
DE69021214D1 (de) Orale zusammensetzung für die behandlung intestinaler entzündlicher krankheiten.
EP0585681A3 (de) Verwendung des IL-4-Rezeptors zur Therapie, Prophylaxe und Diagnose von allergischen, viralen, parasitären und bakteriellen Erkrankungen sowie von Pilzinfektionen.
FI102177B1 (fi) Menetelmä uusien terapeuttisesti aktiivisten kromaani- ja tiokromaanijohdannaisten valmistamiseksi ja välituotteet
SE7905593L (sv) Acylderivat av karnitin och forfarande for framstellning derav
NO972391L (no) 2-substituerte 1,2,5-tiadiazolidin-3-on 1,1-dioksider og preparater og metoder for anvendelse derav
EP0270690A4 (en) MEDICINES FOR THE TREATMENT AND PROPHYLAXIS OF LIVER AND KIDNEY DISEASES.
NO161972C (no) Analogifremgamgsmaate ved fremstilling av terapeutisk aktive 1-substituerte tetralinderivater.
TR199700956T1 (xx) Indazolkarboksamidler.
NO943288L (no) Anvendelse av pentoksyfyllin ved fremstilling av farmasöytiske preparater til behandling av granulomatöse og fibroserende lungesykdommer
DE3889974D1 (de) Pyrazol-Derivate und diese enthaltende Behandlungsmittel für cerebrovaskulare Krankheiten.
ES2153842T3 (es) Derivados de 3-oxo-pirido(1,2-a-)bencimidazol-4-carboxilo y de 4-oxo-azepino(1,2-a)bencimidazol-5-carboxilo utiles en el tratamiento de enfermedades del sistema nervioso central.
DK0521057T3 (da) Farmaceutiske midler indeholdende ipriflavon, fremgangsmåde til fremstilling deraf, og relativ terapeutisk anvendelse
NO162557C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive (pyrrol-1-yl)-fenyldihydropyridazinoner.
NO172114C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte bifenyler
DE69719190D1 (de) Kolostrum enthaltende pharmazeutische zusammensetzungen und deren verwendung
IT1243368B (it) Uso del bendazac e dei suoi sali farmaceuticamente accettabili
FR2718444B1 (fr) Dérivés de (3-méthyl-1, 2, 3, 4-tétrahydroquinoléin-8-yl)sulfonyle, leur préparation et leur application en thérapeutique.